In this preview, Marc de Garidel, CEO of Abivax, shares the moment a phase 3 trial delivered results far beyond expectations — a rare scientific milestone that triggered an intense 48-hour sprint and a record-breaking stock surge.

🎧 The full episode drops tomorrow on Pharma minds.

What you will learn in the full episode of tomorrow:

◾️ How Marc stepped into a company with almost no long-term plan… and why that turned out to be a surprising advantage.

◾️ The four pillars of a new strategy — and how one of them quietly set the stage for the breakthrough to come.

◾️ What it really takes to run a global phase 3 across dozens of countries — and why Abivax had to reinvent itself to pull it off.

◾️ A mechanism of action unlike anything else in IBD — and why this difference matters more than most people think.

◾️ The hidden lessons from a noisy phase 2 that helped transform the phase 3 into something no one saw coming.

◾️ A leadership philosophy built on transparency and speed, born from a single principle: in biotech, every day counts.

◾️ The unexpected market reaction that changed the fate of the company overnight — with numbers that almost don’t seem real.

A clear, concrete, and inspiring episode that sheds light on how Europe can regain its leadership in healthcare innovation.

See you tomorrow!

---

🎧 New here? To get a quick overview of the episodes, download “25 Tips for Purposeful Leadership”, a guide inspired by the best advice shared by my guests.

🤝 Want to connect or talk about your current challenges? Let’s connect on LinkedIn.

📩 Curious to dive deeper into the major shifts in the pharma and healthcare ecosystem? Subscribe to the Pharma Minds newsletter.

Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.